Jayex Technology Share Price and Company Fundamentals
Last traded: Last Friday at 12:29 AM
Jayex Technology Limited develops healthcare industry service technologies and integrated dispensing automation systems for the pharmaceutical and healthcare sectors in Australia and the United Kingdom. It offers Jayex Connect platform, a cloud-based patient engagement platform, which allow users for appointment booking, patient calling, patient check-in, health messaging, and script management. The company was formerly known as Jayex Healthcare Limited and changed its name to Jayex Technology Limited in May 2021. Jayex Technology Limited was founded in 2006 and is based in Milton, Australia.
Key Metrics
PE ratio
-
PB ratio
1.59
Dividend yield
Beta
1.19
Market cap
$5.95M
Enterprise value
$9.05M
Company profile
| Primary activities | Healthcare Service Provider |
|---|---|
| Industry / Sector | Health Information Services / Healthcare |
| Website | http://www.jayex.com/en-au/ |
| Mailing address | 17B Cribb Street Milton QLD 4064 Australia |
| Phone / Fax | 1300 330 611 / |
| Share registry | AUTOMIC REGISTRY SERVICES |
Dividends
Jayex Technology does not pay dividends.
Company Executives
As of Jul 2021, following are the company executives and directors listed on Jayex Technology.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Michael Denis Boyd B.Com., B.Comm, Grad.Dip., ASIA, CA, FAIC | Exec. Chairman | 54 | 149.59k |
| Nathan Woodard | Chief Financial Officer | 158.05k | |
| Ms. Melanie Jaye Leydin C.A., B.Bus, CA | Company Sec. | 47 |
Profitability and management effectiveness
Profit margin
-12.09%
Operating margin
-13.82%
Return on assets
-4.41%
Return on equity
-21.20%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Jayex Technology is 5.95M and its enterprise value is 9.05M. The enterprise value to revenue ratio of JTL is 1.37.
The JTL's stocks Beta value is 1.19 making it 19% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Jayex Technology (JTL)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Jayex Technology (ASX:JTL) Frequently Asked Questions
1. What is Jayex Technology's Stock Symbol?
Jayex Technology trades on ASX under the ticker symbol "JTL".
2. What is Jayex Technology's stock price today?
One share of JTL stock can currently be purchased for approximately $0.027.
3. How can I contact Jayex Technology?
Jayex Technology's mailing address is 17B Cribb Street Milton QLD 4064 Australia. The company can be reached via phone at 1300 330 611.
4. What is Jayex Technology's official website?
The official website of Jayex Technology is http://www.jayex.com/en-au/.
5. Which share registry manages Jayex Technology's stock?
Jayex Technology's stock is managed by AUTOMIC REGISTRY SERVICES.